These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 12072)

  • 1. Studies on the dynamics and mechanism of glibenclamide-induced insulin secretion.
    Basabe JC; Farina JM; Chieri RA
    Horm Metab Res; 1976 Nov; 8(6):413-9. PubMed ID: 12072
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antagonism of the stimulatory effects of efaroxan and glibenclamide in rat pancreatic islets by the imidazoline, RX801080.
    Brown CA; Chan SL; Stillings MR; Smith SA; Morgan NG
    Br J Pharmacol; 1993 Nov; 110(3):1017-22. PubMed ID: 7905338
    [TBL] [Abstract][Full Text] [Related]  

  • 3. alpha2A-adrenoceptor antagonism increases insulin secretion and synergistically augments the insulinotropic effect of glibenclamide in mice.
    Fagerholm V; Scheinin M; Haaparanta M
    Br J Pharmacol; 2008 Jul; 154(6):1287-96. PubMed ID: 18493247
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The influence of pentoxyfylline [1-(5-oxohexyl-) 3,7-dimethylxanthine] (BL 191) on the insulin secretion induced by glibenclamide and by arginine/glucose in the perfused pancreas.
    Basabe JC; Udrisar DP; Knopf CF; Aparicio N
    Acta Diabetol Lat; 1977; 14(5-6):263-72. PubMed ID: 418615
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interactions between imidazoline compounds and sulphonylureas in the regulation of insulin secretion.
    Mourtada M; Brown CA; Smith SA; Piercy V; Chan SL; Morgan NG
    Br J Pharmacol; 1997 Jun; 121(4):799-805. PubMed ID: 9208151
    [TBL] [Abstract][Full Text] [Related]  

  • 6. B cell adrenoceptors and sulphonylurea-induced insulin release in mouse islets.
    Garrino MG; Henquin JC
    Diabetologia; 1990 Mar; 33(3):145-7. PubMed ID: 1970317
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chronic sympathetic innervation of islets in transgenic mice results in differential desensitization of alpha-adrenergic inhibition of insulin secretion.
    Grodsky GM; Ma YH; Edwards RH
    Adv Exp Med Biol; 1997; 426():129-38. PubMed ID: 9544265
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interacting effects of sulfonylureas and glucose on cyclic AMP metabolism and insulin release in pancreatic islets of the rat.
    Grill V; Cerasi E
    J Clin Invest; 1978 May; 61(5):1346-54. PubMed ID: 207736
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insulin secretion in the perinatal period of the rat in vivo and in vitro effects of glucose and gibenclamide (HB 419).
    Heinze E; Beischer W; Osorio J; Pfeiffer EF
    Diabetologia; 1975 Aug; 11(4):313-20. PubMed ID: 812756
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Signaling and sites of interaction for RX-871024 and sulfonylurea in the stimulation of insulin release.
    Efanov AM; Zaitsev SV; Efanova IB; Zhu S; Ostenson CG; Berggren PO; Efendić S
    Am J Physiol; 1998 Apr; 274(4):E751-7. PubMed ID: 9575838
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The role of cyclic AMP in the control of insulin secretion (author's transl)].
    Cerasi E; Grill V
    MMW Munch Med Wochenschr; 1977 Sep; 119(38):1229-36. PubMed ID: 198651
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ethanol influence on insulin secretion from isolated rat islets.
    Singh SP; Patel DG; Snyder AK; Pullen GL
    Experientia; 1986 Jan; 42(1):58-60. PubMed ID: 3002841
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the effects of efaroxan and glibenclamide on plasma glucose and insulin levels in rats.
    Berridge TL; Doxey JC; Roach AG
    Eur J Pharmacol; 1992 Mar; 213(2):213-8. PubMed ID: 1355734
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes in glucose-stimulated insulin secretion after long-term treatment of C57BL mice with glibenclamide.
    Schmidt S; Wilke B; Ziegler B; Jahr H; Zühlke H
    Endokrinologie; 1980 Oct; 76(2):163-70. PubMed ID: 6778692
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exposure to glibenclamide increases rat beta cells sensitivity to glucose.
    Patanè G; Piro S; Anello M; Rabuazzo AM; Vigneri R; Purrello F
    Br J Pharmacol; 2000 Mar; 129(5):887-92. PubMed ID: 10696086
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modulation by IBMX, fasting and experimental diabetes of glibenclamide-induced islet hormone release from the perfused rat pancreas.
    Ostenson CG; Grill V; Nylén A; Efendić S
    Diabete Metab; 1983 Mar; 9(1):58-65. PubMed ID: 6189748
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alterations of insulin secretion from mouse islets treated with sulphonylureas: perturbations of Ca2+ regulation prevail over changes in insulin content.
    Anello M; Gilon P; Henquin JC
    Br J Pharmacol; 1999 Aug; 127(8):1883-91. PubMed ID: 10482920
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of in vitro maturation of stimulus-secretion coupling in fetal rat islet beta-cells.
    Sjöholm A; Sandberg E; Ostenson CG; Efendic S
    Endocrine; 2000 Jun; 12(3):273-8. PubMed ID: 10963048
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cyclic AMP and insulin release.
    Grill V
    Acta Paediatr Scand Suppl; 1977; (270):41-7. PubMed ID: 210617
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of D-phenylalanine-derivative hypoglycemic agent A-4166 on pancreatic alpha- and beta-cells: comparative study with glibenclamide.
    Hirose H; Maruyama H; Seto Y; Ito K; Fujita T; Dan K; Kanda N; Saruta T; Kato R
    Pharmacology; 1995 Mar; 50(3):175-81. PubMed ID: 7746834
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.